BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24122302)

  • 1. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials.
    Schiffman SC; Nowacki MR; Spencer L; McMasters KM; Scoggins CR; Martin RC
    J Surg Oncol; 2014 Feb; 109(2):98-103. PubMed ID: 24122302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
    Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
    Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
    Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current management and prognosis of intrahepatic cholangiocarcinoma in France].
    Borie F; Niampa H; Bouvier AM; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
    Gastroenterol Clin Biol; 2009; 33(10-11):971-6. PubMed ID: 19647386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
    Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
    Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
    Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of intrahepatic cholangiocarcinoma--a single center experience.
    Lanthaler M; Biebl M; Strasser S; Weissenbacher A; Falkeis C; Margreiter R; Nehoda H
    Am Surg; 2010 Apr; 76(4):411-7. PubMed ID: 20420253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
    Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
    Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
    Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
    Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of serum γ-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study.
    Yin X; Zheng SS; Zhang BH; Zhou Y; Chen XH; Ren ZG; Qiu SJ; Fan J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1408-14. PubMed ID: 23839159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.